Seizure action plans in the pediatric population with epilepsy: Uptake, determinants, and parental interest in a

Michelle Chiu1, Sharon Peinhof1, Conrado De Guzman1

  • 1University of British Columbia and British Columbia Children's Hospital, Division of Neurology, Department of Pediatrics, Vancouver, BC, Canada.

Insights

Most pediatric epilepsy patients lack seizure action plans (SAPs), increasing risks during status epilepticus (SE). Parents show high interest in a SAP mobile app, highlighting a need for better SAP uptake and digital tool integration for pediatric epilepsy management.

Area of Science:

  • Pediatric Neurology
  • Epilepsy Management
  • Digital Health

Background:

  • Status epilepticus (SE) is a critical pediatric neurological emergency.
  • Timely treatment and appropriate dosing of rescue medications are crucial for minimizing SE-related morbidity and mortality.
  • Seizure action plans (SAPs) are vital tools for parents and caregivers to manage SE effectively.

Purpose of the Study:

  • To determine the prevalence of Seizure Action Plans (SAPs) in a pediatric epilepsy population.
  • To identify factors associated with SAP adoption.
  • To assess parental interest in a dedicated SAP mobile application for epilepsy management.

Main Methods:

  • A survey was administered to parents of pediatric epilepsy patients at British Columbia Children's Hospital.
  • Chart review and univariate/multivariate analyses were conducted to identify predictors of SAP possession.
  • A systematic search for available epilepsy management mobile applications was performed.

Main Results:

  • 62% of the 192 surveyed participants reported having a SAP.
  • Prior SE history and male gender were associated with a higher likelihood of having a SAP.
  • 83% of parents expressed interest in a SAP mobile application, yet only 15% currently use epilepsy management apps.

Conclusions:

  • There is a significant need to improve SAP adoption rates in pediatric epilepsy, especially for high-risk individuals.
  • A SAP mobile application is perceived as valuable by most parents for managing their child's epilepsy.
  • A notable gap exists between parental interest in epilepsy management apps and their actual utilization.
Abstract

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
801
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
594
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
415
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
903
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
913
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
667